# OnCo record alchemist (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/alchemist/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "alchemist", "NCT02194738" ;
  schema:name "ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)"@en ;
  schema:alternateName "ALCHEMIST screening"@en, "A151216"@en, "ALCHEMIST trials"@en ;
  schema:description "ALCHEMIST tests thousands of people whose early lung cancer has just been removed, finds the small fraction with an EGFR or ALK change, and offers them a trial of the matching pill after surgery, with everyone else offered an immunotherapy trial. It is the adjuvant version of a lung cancer umbrella trial."@en ;
  schema:url <https://onco.cc/trials/alchemist/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02194738>, <https://clinicaltrials.gov/study/NCT02193282>, <https://clinicaltrials.gov/study/NCT02201992>, <https://clinicaltrials.gov/study/NCT02595944>, <https://www.cancer.gov/types/lung/research/alchemist> ;
  onco:status "active" ;
  onco:phase "platform" ;
  schema:startDate "2014-09-26" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/resectable-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/erlotinib/>, <https://onco.cc/drugs/crizotinib/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/alectinib/> ;
  onco:companies <https://onco.cc/companies/alliance-oncology/>, <https://onco.cc/companies/ecog-acrin/>, <https://onco.cc/companies/swog/>, <https://onco.cc/companies/nrg-oncology/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/master-protocol/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/basket-umbrella-platform/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-alchemist-jama-oncol-2022/> .